Company Monitoring Page for Delcath

latest headlines for company on cafepharma

Delcath to trial Hepzato drug device combo in colorectal cancer
Clinical Trials Arena
Tue, 12/3/24 - 09:38 am
Tags:
Delcath, Hepzato, colorectal cancer, drug-device combos
Delcath Gets FDA Approval for Cancer Drug-Device Combo 10 Years After Rejection
BioSpace
Wed, 08/16/23 - 10:21 am
Tags:
Delcath, drug-device combos, FDA, Hepzato, uveal melanoma
Greater Fools Love Delcath, Zalicus On Orphan Drug Derpitude
TheStreet.com
Wed, 10/2/13 - 02:38 pm
Tags:
Delcath, Zalicus, orphan drugs, Chemosat, liver cancer
Delcath dives again on final FDA denial of liver cancer treatment
Mass Device
Mon, 09/16/13 - 11:19 am
Tags:
Delcath, FDA, liver cancer, devices, Melblez
2013 FDA Drug Approval Calendar
TheStreet.com
Tue, 05/21/13 - 12:05 pm
Tags:
drug approvals, GSK, Dolutegravir, Trametenib, Auxilium, Xiaflex, Delcath, Melblez, Seattle Genetics, Adcetris, Antares, Otrexup, Amag Pharmaceuticals, Feraheme, Cubist Pharmaceuticals, Entereg, Gilead, sofosbuvir, Amarin, Vascepa, Merck, suvorexant, Valeant Pharmaceuticals, efinaconazole, Depomed, Sefelsa, Zogenix, Zohydro, dabrafenib, tivozanib, Aveo Pharmaceuticals
FDA advisers recommend against Delcath's cancer therapy
Reuters
Fri, 05/3/13 - 08:59 am
Tags:
FDA, advisory panels, Delcath, Melblez
Aveo, Delcath FDA Panel Live Blog
TheStreet.com
Thu, 05/2/13 - 10:52 am
Tags:
FDA, advisory panels, tivozanib, Delcath, Aveo Oncology, kidney cancer, Melblez
Delcath: A Cancer Treatment Biotech With Good Short And Long-Term Potential
Seeking Alpha
Mon, 04/22/13 - 11:22 am
Tags:
Delcath, liver cancer
Most Profitable Second Quarter Biotech Stocks
TheStreet.com
Tue, 04/2/13 - 10:58 am
Tags:
Arena Pharmaceuticals, Zogenix, Delcath, Aveo Pharmaceutical, Vivus, Titan Pharmaceuticals, Bristol-Myers Squibb, Merck, Gilead, AbbVie, Amarin, Achillion, Sangamo BioSciences, Raptor Pharmaceuticals, Vertex Pharmaceuticals, NewLink Genetics, AstraZeneca, Rigel, Depomed, Biogen Idec, Sucampo, Dendreon, Valeant Pharmaceuticals, GSK, Aegerion
2 Cancer Biotechs With Upcoming FDA Approval Decisions In 2013
Seeking Alpha
Sat, 03/23/13 - 09:00 am
Tags:
Delcath, Aveo Pharmaceutical, tivozanib, renal cell carcinoma, Chemosat, melanoma, metastatic melanoma
Best And Worst FDA Drug Approval Stocks of 2013
TheStreet.com
Tue, 03/12/13 - 11:45 am
Tags:
Arena Pharmaceuticals, Sarepta, Ziopharm, Delcath, Aveo Pharmaceutical, United Therapeutics, AP Pharma, Titan Pharmaceuticals, Navidea Biopharmaceuticals, Biogen Idec, Raptor Pharmaceuticals
Delcath Systems: Bullish On Melblez FDA Panel Vote And Subsequent Approval
Seeking Alpha
Fri, 03/8/13 - 11:10 am
Tags:
Delcath, FDA, advisory panels, Melblez, ocular melanoma
Is Delcath The Post-Celsion Play On Liver Cancer?
Seeking Alpha
Mon, 02/4/13 - 12:18 pm
Tags:
Delcath, liver cancer, Celsion, Chemosat
Roche Leads Pack for Upcoming FDA Approvals
Motley Fool
Wed, 01/9/13 - 12:20 pm
Tags:
FDA, drug approvals, Roche, T-DM1, Aveo, Delcath, Navidea Biopharmaceuticals, Lymphoseek, tivozanib, chemostat
Cancer: Delcath lands expanded CE Mark for organ-isolating chemo treatment
Mass Device
Tue, 10/23/12 - 11:11 pm
Tags:
cancer, Delcath, CE Mark, chemo
Delcath files new FDA application for chemo drug-device combination
Mass Device
Thu, 08/16/12 - 10:50 pm
Tags:
Delcath, FDA, cancer
BIO CEO Confab Live Blog: Day 2
TheStreet.com
Tue, 02/14/12 - 11:29 am
Tags:
BIO CEO Conference, Pfizer, Indenix, Keryx, Delcath, Oncothyreon, Acorda Therapeutics, Human Genome Sciences, Gilead
Delcath's ChemoSat goes another round with the FDA
Mass Device
Fri, 10/28/11 - 06:21 pm
Tags:
Delcath, chemotherapy, FDA
Delcath taps Miao as CFO
FierceMedicalDevice
Mon, 09/26/11 - 11:00 pm
Tags:
Delcath, Management, CFO
Cancer therapy device maker Delcath drops hard on inconclusive trial results
Mass Device
Tue, 09/6/11 - 10:38 pm
Tags:
cancer, therapy, Delcath, trial

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.